Home/Filings/4/0001104659-24-033620
4//SEC Filing

Dubovsky Filip 4

Accession 0001104659-24-033620

CIK 0001000694other

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 8:46 PM ET

Size

8.8 KB

Accession

0001104659-24-033620

Insider Transaction Report

Form 4
Period: 2024-03-10
Dubovsky Filip
President, R&D
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2024-03-105,3765,376 total
    Common Stock (5,376 underlying)
  • Exercise/Conversion

    Common Stock

    2024-03-10+5,37669,210 total
  • Tax Payment

    Common Stock

    2024-03-10$5.45/sh2,597$14,15466,613 total
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
  • [F2]The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 10, 2022 grant date, in each case subject to continued employment through such vesting date

Issuer

NOVAVAX INC

CIK 0001000694

Entity typeother

Related Parties

1
  • filerCIK 0001977361

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 8:46 PM ET
Size
8.8 KB